In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Somnus Medical Technologies Inc.

Division of Olympus Corp.
www.somnus.com

Latest From Somnus Medical Technologies Inc.

Gyrus and ACMI--A Great Marriage, But What's Next?

The recent acquisition of ACMI by Gyrus boosts both companies considerably and creates a powerful competitor in urology, gynecology, and general surgery. But having created critical mass, have they also attracted the attention of much larger companies--threatening both the comfortable niches they occupy and their independence?
Medical Device

The Shifting Sands of Sleep Apnea

Lack of sleep is bad in its own right, but now the knowledge that obstructive sleep apnea is a risk factor for and even a possible cause of heart disease adds urgency to what the medical community has until recently viewed as a quality of life problem. However, the existing infrastructure for diagnosing and treating OSA can neither handle the current demand nor the expected influx of new patients coming in from the cardiology community. New companies hope to fill gaps in diagnosis and therapy, but they face all the challenges of establishing technological and business approaches in an evolving field, with the need to change practice patterns, educate patients and multiple groups of physicians, and win the buy-in of payers.
Medical Device Platform Technologies

Obesity: Super-Sized Medical Device Market

Obesity is a multi-hundred billion dollar market ready and waiting for device developers to catch up to fill an enormous unmet need. Between the low risk, low benefit drug options for overweight patients, and the high risk, high benefit surgeries for the morbidly obese, there's a huge gap in terms of therapies. This sweet spot covers a segement of over 50 million obese patients without weight loss options. Companies with new devices for obesity hope to serve that population; the market is existing and underserved, reimbursement risk is eliminated--since many patients will pay out of pocket to have weight loss procedures--so the remaining risk revolves around technology. However, technology risk in a multi-factorial disease whose mechanisms are poorly understood is significant.
Medical Device Platform Technologies

IntraPace Inc.

In gastroparesis, IntraPace hopes that a device can accomplish what drugs can't--the appropriate emptying of the stomach. The company is developing gastric pacing devices that use electrical stimulation to influence the gut's contractions. The company believes it can also address other motility disorders, and obesity.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
  • Therapeutic Areas
  • Otolaryngology
  • Respiratory, Pulmonary > Obstructive Sleep Apnea
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Olympus Corp.
  • Senior Management
  • John G Schulte, Pres. & CEO
    Robert D McCulloch, VP, Fin. & CFO
    Edward Luttich, VP, R&D
    Donald Bruce, VP, Worldwide Sales
  • Contact Info
  • Somnus Medical Technologies Inc.
    Phone: (408) 773-9121
    285 N. Wolfe Rd.
    Sunnyvale, CA 94086
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register